Navigation Links
Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
Date:12/10/2007

ress release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2006, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
2. Lexicon Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. Lexicon Appoints Judith Swain, M.D. to Board of Directors
4. Lexicon Pharmaceuticals to Present at ThinkEquity ThinkClinic
5. Lexicon Pharmaceuticals to Present at Bio InvestorForum
6. Lexicon to Report Third Quarter 2007 Financial Results on October 30, 2007
7. Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results
8. Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... (PRWEB) June 02, 2015 ... independent blade-based and rackmount computing and storage infrastructure ... the launch of its high density scale-out, two-in-one ... Cirrascale Slipstream™ RM1622D . The high density, two-in-one ... v4 product family with Intel® Iris™ Pro graphics ...
(Date:6/2/2015)... June 2, 2015   Intrexon Corporation ... biology, announced today the appointment of Olivier ... Consumer Sector.  Mr. Jarry will lead the expansion ... and applications for consumer markets.  ... of experience in leading global life sciences and ...
(Date:6/2/2015)... Ohio , June 2, 2015 GOJO, ... pledged its commitment to antibiotic stewardship at the White ... human and animal health organizations and stakeholders at the ... five years to slow the emergence of antibiotic-resistant bacteria, ... antibiotics, and prevent the spread of resistant infections. ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 Chosen ... health care, Jack Uldrich has been selected as ... New York today. He will deliver his keynote: ... Uldrich has delivered presentations to the American Medical ... Audiology and Neurology, Alcetel-Lucent/Verizon Forum on Wireless Healthcare, ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3Intrexon Announces New Sector Leader 2Intrexon Announces New Sector Leader 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2
... Cardiac Science Corporation, an Opto Circuits Group ... defibrillator (AED) and diagnostic cardiac monitoring devices, announced ... G3 Pro® units to the Hong Kong Department ... http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO ) "This alliance demonstrates ...
... LA JOLLA, Calif., Nov. 15, 2011 DermTech, ... disease detection, announced  it will present results from ... can be used with a high-throughput, low-cost qRT-PCR ... recapitulated on a qRT-PCR system that successfully discriminated ...
... Virobay, Inc., a privately held ... protease inhibitors for the treatment of autoimmune diseases, ... showing that one of the company,s spectrum-selective cathepsin ... bone cancer pain.  Virobay has a series of ...
Cached Biology Technology:Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs 2Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs 3Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs 4DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 2DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 3Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model 2Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model 3
(Date:5/21/2015)... DALLAS , May 21, 2015 ... report, "Thermal Imaging Market by Solutions (Hardware, Software, Services), ... Veterinary, Automotive & others), by End-Users (Military & ... published by MarketsandMarkets, Thermal Imaging Market is expected ... $9998.9 Million by 2020, at a Compound Annual ...
(Date:5/19/2015)... , May 19, 2015  Technology is rapidly ... internally and in the cloud. Passwords and their management ... of OTP and standards-based specifications such as those developed ... outmoded use of passwords presents for BYOD, COPE, IoT, ... unified biometric identity protocol. In response ...
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... of having a sudden cardiac arrest can depend on ... the Canadian Cardiovascular Congress 2012 in Toronto, co-hosted by ... Society. His study of Greater Toronto Area ... arrests found that the factors causing increased risk are ...
... A team of Duke Medicine researchers has engineered cartilage ... sorted for use in tissue repair and studies into cartilage ... 29, 2012, in the journal the Proceedings of the ... stem cells, or iPSCs, may be a viable source of ...
... Wash., Oct. 29, 2012   BioLife Solutions , Inc. ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced the ... than 50 clinical trial-stage cellular therapies, making it the ...
Cached Biology News:Risk of cardiac arrest depends on where you live 2Risk of cardiac arrest depends on where you live 3Duke researchers engineer cartilage from pluripotent stem cells 2BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies 2BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies 3BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies 4
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
Biology Products: